Biogen is paying $7.2 billion to buy a DFW biotech as the new CEO makes good on his promise to expand into the rare disease space.
Biogen is paying $7.2 billion to buy a DFW biotech as the new CEO makes good on his promise to expand into the rare disease space.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.